Your session is about to expire
← Back to Search
Knowledge Sharing + Support for Suicide
N/A
Waitlist Available
Led By Deborah Altschul, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will study whether or not Zero Suicide, a suicide prevention model, is more effective when combined with a cultural component in reducing suicidal ideation and behaviors in American Indian youth.
Eligible Conditions
- Suicide
- Suicidal Thoughts
- Suicidal and Self-Harm Behaviour
- Suicidal Ideation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement in resilience
Reduction in suicidal behavior
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Zero Suicide plus KICKSExperimental Treatment1 Intervention
Participants randomly assigned to the Zero Suicide plus KICKS arm will participate in a weekly intergenerational knowledge sharing group.
Group II: Zero SuicideActive Control1 Intervention
Participants randomly assigned to the Zero Suicide arm will also participate in a weekly support group until the final follow-up time point when they will be crossed-over into the intergenerational knowledge sharing group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intergenerational Knowledge Sharing group
2018
N/A
~230
Find a Location
Who is running the clinical trial?
University of New MexicoLead Sponsor
374 Previous Clinical Trials
3,528,418 Total Patients Enrolled
2 Trials studying Suicide
741 Patients Enrolled for Suicide
Deborah Altschul, PhDPrincipal InvestigatorUniversity of New Mexico
Brandi C Fink, PhDPrincipal InvestigatorOklahoma University Health Sciences Center
Share this study with friends
Copy Link
Messenger